Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

(2023) Steven E. Nissen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

(2023) Steven E. Nissen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence of statin intolerance: a meta-analysis

(2022) Ibadete Bytyçi et al.   EUROPEAN HEART JOURNAL

Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)

(2022) Christie M. Ballantyne et al.   AMERICAN JOURNAL OF CARDIOLOGY

A Meta-Analysis of Cardiovascular Outcomes in Patients With Hypercholesterolemia Treated With Bempedoic Acid

(2020) Abdul Aziz A. Asbeutah et al.   AMERICAN JOURNAL OF CARDIOLOGY

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

(2019) Kausik K. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance

(2019) Ulrich Laufs et al.   Journal of the American Heart Association

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease

(2019) Anne C. Goldberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION